BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 6764377)

  • 1. Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.
    Kerbel RS; Dennis JW; Largarde AE; Frost P
    Cancer Metastasis Rev; 1982; 1(2):99-140. PubMed ID: 6764377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor.
    Kerbel RS; Lagarde AE; Dennis JW; Donaghue TP
    Mol Cell Biol; 1983 Apr; 3(4):523-38. PubMed ID: 6687920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asparagine-linked oligosaccharides in murine tumor cells: comparison of a WGA-resistant (WGAr) nonmetastatic mutant and a related WGA-sensitive (WGAs) metastatic line.
    Dennis JW; Carver JP; Schachter H
    J Cell Biol; 1984 Sep; 99(3):1034-44. PubMed ID: 6547960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent reversion of stable in vitro genetic markers detected in tumour cells from spontaneous metastases.
    Dennis J; Donaghue T; Florian M; Kerbel RS
    Nature; 1981 Jul; 292(5820):242-5. PubMed ID: 6894784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in sensitivity to nonspecific cell-mediated lysis associated with tumor progression: characterization of activated macrophage- and natural killer cell-resistant tumor variants.
    Nestel FP; Casson PR; Wiltrout RH; Kerbel RS
    J Natl Cancer Inst; 1984 Aug; 73(2):483-91. PubMed ID: 6589440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic studies of membrane mutants of a highly metastatic murine tumor.
    Kerbel RS
    Am J Pathol; 1979 Dec; 97(3):609-22. PubMed ID: 507193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial reversion of the metastatic phenotype in a wheat germ agglutinin-resistant mutant of the murine tumor cell line MDAY-D2 selected with Bandeiraea simplicifolia seed lectin.
    Dennis JW
    J Natl Cancer Inst; 1985 May; 74(5):1111-20. PubMed ID: 3858579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An examination of tumor antigen loss in spontaneous metastases.
    Dennis JW; Donaghue TP; Kerbel RS
    Invasion Metastasis; 1981; 1(2):111-25. PubMed ID: 6985358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-associated alterations detected in poorly tumorigenic lectin-resistant variant sublines of a highly malignant and metastatic murine tumor.
    Dennis JW; Donaghue TP; Kerbel RS
    J Natl Cancer Inst; 1981 Jan; 66(1):129-39. PubMed ID: 6935454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin-resistant variants of mouse Lewis lung carcinoma cells. I. Selection and in vivo properties.
    Dus D; Debray H; Strzadala L; Rak J; Kusnierczyk H; Montreuil J; Radzikowski C
    Clin Exp Metastasis; 1990; 8(3):277-86. PubMed ID: 2328548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice.
    Ishikawa M; Dennis JW; Man S; Kerbel RS
    Cancer Res; 1988 Feb; 48(3):665-70. PubMed ID: 3335029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic and phenotypic evolution of a murine tumor during its progression in vivo toward metastasis.
    Lagarde AE; Donaghue TP; Dennis JW; Kerbel RS
    J Natl Cancer Inst; 1983 Jul; 71(1):183-91. PubMed ID: 6575202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive immune therapy in mice bearing poorly immunogenic metastases, using T lymphocytes stimulated in vitro against highly immunogenic mutant sublines.
    Dennis JW; Laferté S; Man MS; Elliott BE; Kerbel RS
    Int J Cancer; 1984 Nov; 34(5):709-16. PubMed ID: 6437992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different metastatic phenotypes in two genetic classes of wheat germ agglutinin-resistant tumor cell mutants.
    Dennis JW
    Cancer Res; 1986 Sep; 46(9):4594-600. PubMed ID: 3755374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialylation and malignant potential in tumour cell glycosylation mutants.
    Takano R; Muchmore E; Dennis JW
    Glycobiology; 1994 Oct; 4(5):665-74. PubMed ID: 7881181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a metastasis-deficient lectin-resistant human melanoma mutant.
    Ishikawa M; Kerbel RS
    Int J Cancer; 1989 Jan; 43(1):134-9. PubMed ID: 2910825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of in vitro immunoselected variants from a highly metastatic murine tumor for alterations in malignant behavior in vivo.
    Liteplo RG; Frost P; Donaghue TP; Kerbel RS
    Int J Cancer; 1984 May; 33(5):669-75. PubMed ID: 6724741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-resistant variants of mouse melanoma cells. I. Altered metastasizing capacity and tumorigenicity.
    Tao TW; Burger MM
    Int J Cancer; 1982 Apr; 29(4):425-30. PubMed ID: 7085130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asn-linked oligosaccharides in lectin-resistant tumor-cell mutants with varying metastatic potential.
    Dennis JW; Laferté S; Fukuda M; Dell A; Carver JP
    Eur J Biochem; 1986 Dec; 161(2):359-73. PubMed ID: 3780748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fluctuation analysis of the rate of reexpression of the metastatic potential in a nonmetastatic mutant of the MDAY-D2 murine tumor.
    Lagarde AE
    Invasion Metastasis; 1983; 3(1):52-64. PubMed ID: 6677620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.